首页> 外国专利> GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE

机译:遗传工程的T细胞具有Regnase-1和/或TGFBrii破坏具有改善的功能和持久性

摘要

A population of genetically engineered T cells, comprising a disrupted Reg1 gene and/or a disrupted TGFBRII gene. Such genetically engineered T cells may comprise further genetic modifications, for example, a disrupted CD70 gene. The population of genetically engineered T cells exhibit one or more of (a) improved cell growth activity; (b) enhanced persistence; and (c) reduced T cell exhaustion, (d) enhanced cytotoxicity activity, (e) resistant to inhibitory effects induced by TGF-b, and (f) resistant to inhibitory effects by fibroblasts and/or inhibitory factors secreted thereby, as compared to non-engineered T cell counterparts.
机译:一种基因工程的T细胞群,包含破坏的Reg1基因和/或破坏的TGFBRII基因。 这种遗传工程化的T细胞可包括进一步的遗传修饰,例如破坏的CD70基因。 基因工程T细胞的群体表现出一种或多种(a)改善的细胞生长活性; (b)增强持续存在; (c)减少T细胞耗尽,(d)增强的细胞毒性活性,(e)抗TGF-B诱导的抑制作用,(F)与由此分泌的成纤维细胞和/或抑制因素抵抗抑制作用 非工程化T细胞对应物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号